at-home testing kit

By Dave Muoio 03:00 pm June 26, 2020
Israel-based smartphone urinalysis and wound-care startup Healthy.io is purchasing fellow home-diagnostics company Inui Health in a roughly $9 million cash deal, CNBC reports. The agreement also involves milestones that Inui Health will need to meet, and sees CEO Dr. Jaime Tenedorio take on a new role within Healthy.io's team. MobiHealthNews has reached out to both companies for confirmation of...
By Dave Muoio 11:40 am May 19, 2020
Austin, Texas-based EverlyWell, a digital platform that lets consumers order lab tests online and view their results, has received an FDA Emergency Use Authorization (EUA) for a COVID-19 at-home diagnostic sample collection kit that can be used with multiple diagnostic lab tests. Announced Friday by the FDA and Monday by the startup, the EverlyWell COVID-19 Test Home Collection Kit includes nasal...
By Dave Muoio 02:50 pm May 13, 2020
Less than a week after the first home-collected saliva test for COVID-19 was authorized by the FDA, at least two consumer-facing telehealth brands say they have cut deals to sell these test kits to the public. The first is consumer telehealth company Hims & Hers, best known for its mail-order wellness and sexual health products for men and women. While the well-funded startup has...
By Dave Muoio 02:41 pm November 5, 2019
Scanwell Health, maker of a smartphone-based platform for home urinary tract infection screening, has raised $3.5 million in seed funding. Founders Fund, Mayfield, DCM, Version One, Y Combinator and Liquid 2 Ventures all participated in the round. The startup paired this announcement with the reveal of a new partnership with telehealth service Lemonaid Health that will bring its UTI platform to...
By Dave Muoio 09:44 am September 12, 2019
Israeli smartphone urinalysis startup Healthy.io has closed a $60 million Series C funding round led by Corner Ventures, the company announced this morning. Joy Capital Ventures and prior backers Ansonia Holdings, Aleph and Samsung NEXT each participated as well. Furthermore, the company also announced that it has received a second FDA 510(k) clearance intended to support diagnosis of chronic...
By Dave Muoio 09:03 am August 1, 2019
Thriva, a London-based platform providing mail-order blood tests for consumers, has raised another $7.3 million in backing thanks to a new Series A round. Pembroke VCT and Guinness Asset Management were among the round’s participants, which brought the company’s total funds raised to $8.2 million. WHAT THEY DO Since 2016, Thriva has offered mail-order tests and results interpretations to more...
By Dave Muoio 03:09 pm November 1, 2018
Clinical lab and life science services company LabCorp has signaled its latest consumer-focused shift with the announcement of a self-administered wellness test and online results portal. Called Pixel by LabCorp, the testing platform is ordered online by consumers, reviewed by a board-certified physician and then delivered to the consumer within a few days. After collecting a blood sample using...
By Dave Muoio 04:21 pm October 31, 2018
Smartphone blood lab startup 1Drop Diagnostics (not to be confused with other very similarly-named startup 1Drop or One Drop) has raised $4.25 million in a Series A financing round, the company announced today. The funding was led by investor Christian Wildmoser, with additional backing and support by Swiss Startup Group investor Dr. Hans-Peter Strebel, Beat Schillig of IFJ Institute for Young...
By Heather Mack 03:56 pm May 3, 2017
Austin, Texas-based EverlyWell, maker of a digital platform that lets consumers to order lab tests online, provide samples and receive results, has raised another $2 million in a round led by Next Gen Venture Partners. Jack Novak, SoGal Ventures, Full Tilt Capital and other unnamed venture capital firms contributed. Last year, EverlyWell raised $2.5 million, and also had $500,000 in seed funding...
By Heather Mack 05:51 pm February 14, 2017
At-home testing kit company myLab Box has expanded its services with the addition of six new tests for sexually transmitted diseases, bringing the company’s total offerings to 10 tests sold in the United States. The company launched the new tests in response to increasing rates of STDs in the country, along with the uncertain future of healthcare services under a new administration. The new tests...